CPT1A and metabolic syndrome: For example, an EWAS study performed in individuals with MetS demonstrated decreased methylation of CPT1A, a gene with a key role in regulating mitochondrial fatty acid oxidation (FAO), to be correlated with the increased metabolic risk and overall MetS phenotype [25].